A Randomized, Multicenter Trial of Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated Methicillin-resistant Staphylococcus Aureus Bacteremia.

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 08 May 2014

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Daptomycin (Primary) ; Vancomycin
Indications Methicillin-resistant Staphylococcus aureus infections; Nosocomial infections
Focus Therapeutic Use
Acronyms DAVASAB

23 Aug 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
08 Jun 2012 Actual initiation date (1 May 2012) added as reported by ClinicalTrials.gov.
08 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com